Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Olanow

Showing results (21-30 of 160) with videos related to

Pageof 16
Sort By:
Geriatrics|January 1, 1984
A new approach to late onset myasthenia gravisC W Olanow, A Roses
Annals of Neurology|September 28, 1998
Understanding cell death in Parkinson's diseaseP Jenner, C W Olanow
Neurology|December 1, 1996
Oxidative stress and the pathogenesis of Parkinson's diseaseP Jenner, C W Olanow
Neurology|April 1, 1992
Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?C W Olanow, D Calne
Archives of Neurology|August 1, 1982
Valproic acid. Treatment of myoclonus in dyssynergia cerebellaris myoclonicaE R Somerville, C W Olanow
Medical Hypotheses|July 1, 1981
The pathogenesis of myasthenia gravis--a hypothesisC W Olanow, A D Roses
Annals of Neurology|June 1, 1989
Parkinsonism and amiodarone therapyE G Werner, C W Olanow
Neurology|April 3, 1998
An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of NeurologyC W Olanow, W C Koller
Trends in Neurosciences|October 29, 2000
Dopamine receptors: from structure to behaviorS C Sealfon, C W Olanow
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 1, 1994
Magnetic resonance imaging of neurodegenerative diseasesR A Hauser, C W Olanow
Pageof 16

Showing results (21-30 of 160) with videos related to

Sort By:
Pageof 16
Geriatrics|January 1, 1984
A new approach to late onset myasthenia gravisC W Olanow, A Roses
Annals of Neurology|September 28, 1998
Understanding cell death in Parkinson's diseaseP Jenner, C W Olanow
Neurology|December 1, 1996
Oxidative stress and the pathogenesis of Parkinson's diseaseP Jenner, C W Olanow
Neurology|April 1, 1992
Does selegiline monotherapy in Parkinson's disease act by symptomatic or protective mechanisms?C W Olanow, D Calne
Archives of Neurology|August 1, 1982
Valproic acid. Treatment of myoclonus in dyssynergia cerebellaris myoclonicaE R Somerville, C W Olanow
Medical Hypotheses|July 1, 1981
The pathogenesis of myasthenia gravis--a hypothesisC W Olanow, A D Roses
Annals of Neurology|June 1, 1989
Parkinsonism and amiodarone therapyE G Werner, C W Olanow
Neurology|April 3, 1998
An algorithm (decision tree) for the management of Parkinson's disease: treatment guidelines. American Academy of NeurologyC W Olanow, W C Koller
Trends in Neurosciences|October 29, 2000
Dopamine receptors: from structure to behaviorS C Sealfon, C W Olanow
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|July 1, 1994
Magnetic resonance imaging of neurodegenerative diseasesR A Hauser, C W Olanow
Pageof 16